
bm‑t invests in world leading enzyme company
c‑LEcta, a world-leading biotechnology company focused on enzyme engineering and applications in regulated markets like food and pharma, has closed a financing round with Capricorn
c‑LEcta, a world-leading biotechnology company focused on enzyme engineering and applications in regulated markets like food and pharma, has closed a financing round with Capricorn
Investor Days Thüringen is the most important annual event bringing aspiring start-up and growth stage companies together with investors in the federal state of Thüringen.
On his summer tour 2018 “Tiefensee Digital”, Minister Wolfgang Tiefensee visited numerous Thuringian companies and institutions that create unique offerings with digital business models, products
While recently in Berlin meeting with investors we were engaged in an interesting discussion about Initial Coin Offerings (ICOs). Our conversational counterparty, an early-stage private
About half a year ago, ifesca started its Serie A financing round and secured EUR 1 million in the first closing. In the second closing,
InflaRx and current shareholders placed $ 117,3 Mio. of shares, with $ 63 Mio. as primary shares with the proceeds going to InflaRx and $
The Stiftung für Technologie, Innovation und Forschung Thüringen (STIFT) and the Sparkasse Jena-Saale-Holzland invest in an innovative therapeutics company in Jena SmartDyeLivery, in Jena, uses nanoparticles
The Stiftung für Technologie, Innovation und Forschung Thüringen (STIFT) and the Sparkasse Jena-Saale-Holzland invest in an innovative therapeutics company in Jena SmartDyeLivery, in Jena, uses nanoparticles
Worldwide, tuberculosis claims about 1.5 million victims per year. It is one of the most dangerous diseases caused by bacteria. The increasing spread of multi-resistant
bm|t is celebrating its 15th birthday in 2018 and some predecessor organizations/funds date back over 20 years. This long and consistent presence and the valuable networks
The magazine brand eins honours oncgnostics GmbH from Jena as one of the most innovative companies in Germany in the industry “Chemistry, Pharma & Biotechnology”.
BianoGMP GmbH receives investment capital from the Thuringia Start-up Fund (TSF) for the production of DNA- and RNA-based active agents. There is still a lack
The bm|t is pleased to announce that seven of its Investee Partners have already closed funding rounds in 2018. Over €10 million has been raised
Jena-based siOPTICA GmbH has closed a €4M growth financing deal with bm|t and Capital‑E II ARKIV (Capital‑E), Antwerp. With the fresh capital, siOPTICA will extend
Kevin Reeder (Managing Director of bm|t) will give a presentation at the ThEEN (Thüringer Erneuerbare Energien Netzwerk e.V.) specialist forum on 16.04.2018 in Erfurt. The expert
In the 2017 financial year, over EUR 150 million flowed from private domestic and foreign investors from the network of bm‑t beteiligungsmanagement thüringen gmbh (bm|t),
On 19 and 20 June 2018, entrepreneurs and investors will meet for the 15th time at the Investor Days Thuringia at Messe Erfurt. Under the
It’s been just under a year since the founders of ifesca raised the seed round for their start-up. At that time, a high six-figure sum